ASX:CGF

Challenger (CGF) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
6.81 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
3.66%
Price Target
N/A
CGF stock logo

About Challenger Stock (ASX:CGF)

Challenger Limited is a publicly owned investment manager. The company also provides retirement services to its clients. It manages equity mutual funds. The firm invests into the public equity markets across the world. Challenger Limited was founded in 1985 and is based in Australia, Asia and United Kingdom.

CGF Stock News Headlines

348 million Americans lives to END as we know it?
348 million American lives are about to change FOREVER.... Because thanks to one shocking A.I. development I'm revealing for the first time today...
Challenger Limited
348 million Americans lives to END as we know it?
348 million American lives are about to change FOREVER.... Because thanks to one shocking A.I. development I'm revealing for the first time today...
Challenger Ltd CGF
U.S. Challenger Job Cuts
See More Headlines
Receive CGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Challenger and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/13/2019
Ex-Dividend for 3/18 Dividend
2/19/2024
Dividend Payable
3/18/2024
Today
5/06/2024

Industry, Sector and Symbol

Industry
Insurance - Life
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
758
Year Founded
N/A

Profitability

Net Income
$318.10 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.97 billion
Book Value
A$5.70 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.92
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Nicolas Hamilton
    MD, CEO & Director
  • Ms. Alexandra Bell
    Chief Financial Officer
  • Mr. Christopher Plater
    Acting Chief Risk Officer
  • Mr. Victor Rodriguez CPA (Age 53)
    Chief Executive of Funds Management
    Comp: $910.31k
  • Mr. Anton Kapel
    Chief Executive of Life & Solutions, Actuary and CFO of the Life Business
  • Kate Ingwersen
    Chief Executive of Technology
  • Mr. Mark Chen
    General Manager of Investor Relations
  • Jane Keeley
    Head of External Communications
  • Ms. Louise Roche
    Chief Human Resources Officer
  • Mr. Trent L. Alston AMP
    BBuild (Hons), GMQ, Head of Property

CGF Stock Analysis - Frequently Asked Questions

How were Challenger's earnings last quarter?

Challenger Limited (ASX:CGF) issued its quarterly earnings data on Tuesday, August, 13th. The company reported $0.61 EPS for the quarter, missing analysts' consensus estimates of $0.61 by $0.00. Challenger had a trailing twelve-month return on equity of 8.01% and a net margin of 10.53%.

How often does Challenger pay dividends? What is the dividend yield for Challenger?

Challenger declared a Interim dividend on Wednesday, February 14th. Stockholders of record on Monday, March 18th will be paid a dividend of 0.13 per share on Monday, March 18th. This represents a dividend yield of 1.84%. The ex-dividend date of this dividend is Monday, February 19th. This is a boost from the stock's previous Interim dividend of A$0.12.
Read our dividend analysis for CGF
.

Is Challenger a good dividend stock?

Challenger (ASX:CGF) pays an annual dividend of A$0.26 per share and currently has a dividend yield of 3.66%. The dividend payout ratio is 86.67%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for CGF.

What other stocks do shareholders of Challenger own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Challenger investors own include Abbott Laboratories (ABT), BHP Group (BHP), Isentia Group (ISD), South32 (S32), AbbVie (ABBV), Goldman Sachs Physical Gold ETF (AAAU), Argo Investments (ARG), Arcturus Therapeutics (ARCT), Appen (APX) and Afterpay (APT).

This page (ASX:CGF) was last updated on 5/6/2024 by MarketBeat.com Staff

From Our Partners